Kuehn Law investigates Picard Medical directors over alleged shareholder breaches

Verifying
  • Kuehn Law is investigating Picard Medical officers and directors over alleged fiduciary-duty breaches.
  • Investors who purchased PMI before September 2, 2025, are asked to contact the firm.
  • The federal lawsuit alleges misinformation, impersonation and coordinated share dumping involving offshore or nominee accounts.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.